Perry NJ, Encarnacion IN, Desir N, Mehta A, Baker NJ, Alomary SA, Shin DB, Taylor SC, Takeshita J, Margolis DJ, Mollanazar N Reducing New Patient Wait Times in Dermatology Using an Algorithmic Scheduling Strategy , NEJM Catal Innov Care Deliv: 2026,7(8):CAT250274
Alomary SA, Baker NJ, Taylor SC, Mollanazar NK Enhancing dermatology workflow through a replicable epic-based module: Impact on documentation and after-hours electronic medical record use , J Am Acad Dermatol, 95(1): 2026,279-281
Kavanaugh L, Thomas S, Lynch S, Leri D, Xiong RA, Xu L, Snider CK, Ebert JP, Harhay MO, Lu Y, Orwig N, Desir N, Encarnacion IN, Mollanazar N, Thomas R, Bae C, Gitelman Y, Hahn L, Lee K, Mehta SJ, Merchant RM, Delgado MK Automated Calls Added to SMS Reminders Reduce Missed Appointments among High-Risk Patients , NEJM Catal Innov Care Deliv: 2026,7(6):CAT250322
Alomary SA, Baker NJ, Alladeen A, Alkiswani H, Chovatiya R, Dasilva DR, Lewitt GM, Lio PA, Nguyen H, Song EJ, Taylor SC, Mollanazar NK Adalimumab Biosimilars and Access Barriers in Dermatology , J Am Acad Dermatol: 2026
Anusionwu I, Puerta Durango K, Barrera TM, Ogunleye T, Taylor SC, Mollanazar NK The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients with Atopic Dermatitis: A Retrospective Chart Review , J Drugs Dermatol, 24(10): 2025,1054-55
Ruiz Dasilva D, Soto-González A, Mollanazar NK, Ndubisi S, Issa N, Song JE, Shahriari M, Bunick CG, Lio P, Nguyen HP, Yosipovitch G, Del Rosso J Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series , J Clin Aesthet Dermatol, 18(9): 2025,40-46
Mollanazar N, Doran J, Nguyen T, Pivneva I, Signorovitch J, Sullivan R, Voegel A, Uritsky T, et al Delayed biologic initiation is associated with increased healthcare resource use in patients diagnosed with hidradenitis suppurativa , Journal of the American Academy of Dermatology, 93(3): 2025,AB163
Kwatra SG, Pereira MP, Misery L, Mollanazar NK, Shah P, Wiggins S Prurigo nodularis: disease burden, clinical features and approach to management , Br J Dermatol, 193(4): 2025,642-52
Mollanazar N, Isaman DL, Wiggins S, Sivamani RK, Chih-Ho Hong H, Chovatiya R, Yu T, Zahn J, Petruski-Ivleva N, Bosman K, et al: Real-World Medication Use Prior to Dupilumab Initiation Among Adult Patients With Prurigo Nodularis in the US , Journal of the American Academy of Dermatology, 93(3): 2025,AB285
Anusionwu I, Puerta Durango K, Barrera TM, Ogunleye T, Taylor SC, Mollanazar N The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients with Atopic Dermatitis: A Retrospective Chart Review , J Drugs Dermatol, 24(8): 2025,8749
